Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 923093 STAMFORD, CT

Position in VNDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$706,582
-$74,764 QoQ
Shares Held
102,255
+15.4% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in VNDA Over Time

Shares Held

Position Value (USD)

Derivatives in VNDA

reported options exposure · as of Mar 31, 2021
CallValue
$0
CallShares
0
PutValue
$0
PutShares
422,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in VNDA

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $706,582 102,255
2025-12-31 $781,346 88,588
2025-09-30 $641,893 128,636
2025-06-30 $648,004 137,289
2025-03-31 $617,038 134,431
2024-12-31 $117,920 24,618
2024-09-30 $72,404 15,438
2024-03-31 $571,454 139,040
2023-12-31 $153,658 36,412
2022-12-31 $79,368 10,740
2022-06-30 $720,642 66,114
2022-03-31 $1,112,406 98,356
2021-12-31 $1,059,231 67,510
2021-09-30 $305,949 17,850
2021-06-30 ALXN 907,855
2021-06-30 $761,884 35,420
2021-03-31 ALXN 527,741
2021-03-31 ALXN 422,200
2021-03-31 $829,900 55,253
2020-12-31 ALXN 333,377
2020-12-31 $272,720 20,755
2020-09-30 ALXN 72,000
2020-09-30 $316,645 32,779
2020-06-30 ALXN 19,595
2020-06-30 $297,428 25,999
2020-03-31 ALXN 24,097
2020-03-31 $1,135,559 109,610